These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24550061)

  • 1. Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm?
    Barnes NC; Jones PW; Davis KJ
    Thorax; 2014 Jun; 69(6):598-9. PubMed ID: 24550061
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.
    Halpin DM; Dahl R; Hallmann C; Mueller A; Tashkin D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():239-59. PubMed ID: 25709423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium Respimat inhaler and the risk of death in COPD.
    Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
    N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch.
    Hanada S; Wada S; Ohno T; Sawaguchi H; Muraki M; Tohda Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():69-77. PubMed ID: 25609941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?
    Mathioudakis AG; Chatzimavridou-Grigoriadou V; Evangelopoulou E; Mathioudakis GA; Siafakas NM
    Pulm Pharmacol Ther; 2014 Aug; 28(2):91-7. PubMed ID: 24846455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
    Verhamme KM; Afonso A; Romio S; Stricker BC; Brusselle GG; Sturkenboom MC
    Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
    Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
    Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M; Fujimoto T; Fukuchi Y
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of tiotropium--the FDA's conclusions.
    Michele TM; Pinheiro S; Iyasu S
    N Engl J Med; 2010 Sep; 363(12):1097-9. PubMed ID: 20843240
    [No Abstract]   [Full Text] [Related]  

  • 15. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials.
    Singh S; Loke YK; Enright PL; Furberg CD
    BMJ; 2011 Jun; 342():d3215. PubMed ID: 21672999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium inhaler devices: seeking convenience when mortality is at stake?
    Mathioudakis AG; Mathioudakis GA
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):120. PubMed ID: 23025453
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease.
    Covelli H; Bhattacharya S; Cassino C; Conoscenti C; Kesten S
    Pharmacotherapy; 2005 Dec; 25(12):1708-18. PubMed ID: 16305289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium bromide: a long-acting anticholinergic bronchodilator for the treatment of patients with chronic obstructive pulmonary disease.
    Joos GF; Brusselle G; Derom E; Pauwels R
    Int J Clin Pract; 2003 Dec; 57(10):906-9. PubMed ID: 14712894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.